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AKTIVITI ANTI-INFLAMASI EKSTRAK AGERATUM CONYZOIDES LINN., 
LANTANA CAMARA LINN., DAN PSIDIUM GUAJAVA LINN 
 
ABSTRAK 
 
 Dalam percubaan untuk mendapatkan agen anti-inflamasi yang lebih poten 
tetapi mempunyai kurang kesan sampingan, fraksinasi berpandukan aktiviti 
dijalankan terhadap Ageratum conyzoides Linn., Lantana camara Linn., dan Psidium 
guajava Linn..  Ekstrak-ekstrak tersebut disaring dengan model haiwan tapak kaki 
belakang tikus aruhan ‘carrageenan’.  Pada permulaannya, model ini dioptimasikan 
untuk memperolehi agen pengampaian yang paling baik untuk agen anti-inflamasi 
yang tidak larut air seperti indometasin / ekstrak dan menentukan jenis haiwan 
ujikaji yang paling peka terhadap perencatan pembentukan edema oleh indometasin.  
Didapati bahawa ‘compound tragacanth’ (1 %) merupakan agent pengampaian yang 
terbaik dibandingkan dengan karboksi metil selulosa (CMC) (0.5 %), tween 80 (1 %), 
dan kombinasi tween 80 / etanol / air suling (5 : 5: 90) (1%).  Haiwan yang 
menunjukkan perencatan terbesar terhadap pembentukan aruhan edema 
‘carrageenan’ oleh indometasin mengikut turutan berikut iaitu tikus betina > tikus 
jantan > mencit jantan > mencit betina.  Bahan-bahan tumbuhan diekstrak secara 
bersiri dengan pelarut-pelarut berbeza seperti eter petroleum, kloroform, methanol.  
Ekstrak methanol daun L. camara didapati memberikan perencatan edema yang 
paling kuat berbanding dengan ekstrak lain.  Oleh yang demikian, ekstrak methanol 
daun L. camara difraksikan kepada fraksi eter petroleum, kloroform, etil asetat, 
butanol, dan akuas (air suling) dengan cara partisi pelarut-pelarut.  Didapati fraksi 
kloroform memberikan kesan perencatan yang paling ketara terhadap pembentukan 
edema di kaki belakang tikus betina.  Fraksi kloroform ini kemudian difraksikan lagi 
xvi 
kepada empat subfraksi (CF1 - CF4) dengan menggunakan kromatografi turus.  
Keputusan yang diperolehi menunjukkan bahawa subfraksi CF4 adalah paling 
efektif dalam mengurangkan pembentukan edema yang diaruhkan oleh 
‘carrageenan’ dalam tikus betina.  Kemudian, kesan subfraksi CF4 L. camara Linn. 
ini dikaji ke atas kontraksi sediaan terasing uterus tikus aruhan oksitosin dan 
asetilkolina, untuk mengkaji sama ada aktiviti anti-inflamasi ini disebabkan oleh 
perencatan terhadap sintesis prostaglandin.  Keputusan menunjukkan bahawa 
subfraksi CF4 merencat aktiviti kontraksi yang diaruhkan oleh oksitosin dan 
asetilkolina secara tidak kompetitif yang mencadangkan bahawa aksi subfraksi CF4 
adalah tidak spesifik.  Kemungkinan penghalangan saluran kalsium yang 
dioperasikan voltan (VOCCs) dan saluran kalsium dalam sel oleh fraksi CF4 dikaji 
menggunakan sediaan terasing vas deferens tikus.  Keputusan kajian ini 
mencadangkan bahawa subfraksi CF4 secara selektif menghalang saluran kalsium 
dalam sel berbanding dengan VOCC.  Penyaringan fitokimia dengan kromatografi 
lapisan nipis telah dijalankan terhadap fraksi aktif L. camara Linn. untuk 
mengenalpasti kelas-kelas  kompaun yang terdapat di dalam fraksi tersebut.  
Keputusan memaparkan bahawa subfraksi CF4 mengandungi glikosida kardiak, 
sebatian pahit, saponin, terpenoid, dan minyak pati.  Kajian ini menyimpulkan 
bahawa esktrak Lantana camara berupaya memberi aktiviti anti-inflamasi melalui 
penghalangan saluran kalsium dalam sel. 
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ANTI-INFLAMMATORY ACTIVITY OF AGERATUM CONYZOIDES LINN. , 
LANTANA CAMARA LINN. AND PSIDIUM GUAJAVA LINN. EXTRACTS 
 
ABSTRACT 
 
 In an attempt to seek for more potent and less side effects anti-inflammatory 
agent(s), activity guided fractionation was performed on Ageratum conyzoides Linn., 
Lantana camara Linn. and Psidium guajava Linn. extracts. The extracts were 
screened using animal model carrageenan induced hind paw oedema.  The model 
was optimised first to find the best suspending agent for water insoluble anti-
inflammatory agent indomethacin/extracts and to determine the type of experimental 
animals most sensitive to indomethacin inhibition of oedema.  Compound tragacanth 
(1%) was found to be the best suspending agents compared to carboxymethyl 
cellulose (CMC) (0.5%),  tween 80 (1%),and tween 80/ ethanol/ water (5: 5: 90) 
(1%).  The animals that gave the largest inhibition of carrageenan-induced oedema 
to indomethacin was in the order of female rat > male rat > male mice > female mice.  
The plant materials were serially extracted with different solvent e.g. petroleum ether, 
chloroform and methanol.  The methanolic extract of L. camara leaves was found to 
give the best inhibition of oedema compared to other extracts.  Therefore, the 
methanolic L. camara leaves extract was fractionated into petroleum ether, 
chloroform, ethyl acetate, butanol and aqueous fractions using solvent-solvent 
partition method.  It was found that the chloroform fraction caused the strongest 
inhibition on female rat hind paw oedema. The choloroform fraction was further 
fractionated into four subfractions (CF1 to CF4) using column chromatography.  
Results showed that CF4 was the most effective in reducing the oedema induced by 
carrageenan in female rats.  The effect of CF4 of L. camara Linn. was then 
xviii 
examined on the oxytocin and acetylcholine induced contraction in isolated rat 
uterus preparation to investigate whether the anti-inflammatory activity is due to the 
inhibition of prostaglandins synthesis.  Result showed that CF4 inhibited the 
contraction induced by both oxytocin and acetylcholine in non-competitive manner 
which suggests that the action of CF4 is non specific.  The possible blockade of 
voltage-operated calcium channels (VOCCs) and intracellular calcium channels of 
CF4 fraction was investigated using isolated rat vas deferens preparation.  Results 
obtained suggested that CF4 selectively blocks intracellular calcium channel rather 
than VOCCs.  The phytochemical screening using thin layer chromatography was 
performed on the active fractions of Lantana camara to identify the classes of 
compounds present in this fraction.  The result indicated that CF4 contains cardiac 
glycosides, bitter principles, saponins, terpenoids, and essential oil.  This study 
concluded that the Lantana camara extracts are able to exert anti-inflammatory 
activity through blockage of the intracellular calcium channel. 
 1
Chapter 1  Introduction 
1.1 Introduction 
 Inflammation is a normal, protective, complex, homeostastic process.  When 
tissue injury is caused by a single, non-lethal, finite event, such as mechanical 
trauma, a thermal or chemical burn, or a single exposure to a non-replicating 
antigen, the inflammatory and reparative processes begin smoothly from injury to 
healing.  In this circumstance, the whole inflammatory process is truly beneficial and 
provides an example of normal, healthy state.  In contrast, when the response 
becomes too great, it may be far worse than the disease state that its counteracted, 
and in extreme cases, it may be fatal.  These defensive responses may be 
inappropriately directed against innocuous substance from outside the body (e.g. 
pollen) or against the tissues of body itself, and the response themselves may then 
produce damage and may indeed constitute part of the disease process either 
acutely as in anaphylaxis, or chronically as in asthma or rheumatoid arthritis, or in 
atherosclerosis.  Therefore, anti-inflammatory agents are required for these 
conditions.  It is believed that aging processes are all inflammatory responses 
(Turner, 1965).  The importance of anti-inflammatory agents cannot be exaggerated 
because of their utility, often as life- saving drugs (Turner, 1965), in many diseases 
such as arthritis, lupus erythematosus, pemphigus, gout, psoriasis, osteoarthritis 
and rheumatic fever (Paulus, 1974). 
 Currently, the main anti-inflammatory agents available on the market are the 
glucocorticoids and the nonsteroidal anti-inflammatory drugs (NSAIDs).  
Glucocorticoids have powerful anti-inflammatory activity by inhibiting not only initial 
redness, heat, pain and swelling, but also involve in the later stages of wound 
healing and repair, and the proliferative reactions seen in chronic inflammation.  The 
consequence of these powerful actions of the glucocorticoids is that they can be of 
immense value when used to treat certain conditions in which there is 
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hypersensitivity and unwanted inflammation, but they carry the hazard that they can 
suppress the necessary protective responses to infection and can decrease 
essential healing processes.  The incidence of cataracts is higher after prolonged 
administration of the glucocorticoids in patients with rheumatoid arthritis.  Other toxic 
effects, which have been reported, are glaucoma, raised intracranial pressure, 
hypercoagulability of the blood, fever and disorders of menstruation (Rang et al., 
2007).  As a result, there are severe limitations to the use of glucocorticoids in the 
chronic inflammatory disease. 
 Nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most widely 
used of all therapeutic agents.  They are frequently prescribed for “rheumatic” 
musculoskeletal complaints and the common inflammatory joint disease.  However, 
virtually all currently available NSAIDs can have significant unwanted effects, 
especially in the elderly.  When NSAIDs are used in joint diseases (which usually 
necessitates fairly large doses and long-continued use), there is a high incidence of 
side effects --- more particularly in the gastro-intestinal tract but also in the liver, 
kidney, spleen, blood and bone marrow (Rainsford and Velo, 1992).  Common 
gastro-intestinal side effects are dyspepsia, diarrhoea (but sometimes constipation), 
nausea and vomiting.  It has been estimated that one in five chronic users of 
NSAIDs will have gastric damage, which can be silent but carries a small but definite 
risk of serious haemorrhage and / or perforation.  The second most common 
unwanted effect of NSAIDs is skin reactions, such as mild rashes, urticaria and 
photosensitivity reactions to more serious and potentially fatal diseases (Rang et al., 
2007).  Although some recent anti-inflammatory drugs claim to have less of these 
effects, usually it also meant reduced anti-inflammatory activity (Asmawi et al., 
1993). 
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 Clearly, there is a tremendous need for the introduction of more effective and 
less toxic anti-inflammatory agents into clinical use and particularly which have 
novel modes of action.  Efforts to develop new, clinically effective pharmaceutical 
agents traditionally have relied most primarily on the use of existing agents, i.e. 
derivatisation of existing agents, synthesis of additional analogs of existing agents, 
use of combination therapy of existing agents with other drugs, improvement of 
delivery of existing agents to target site, and discovery of new prototype 
pharmaceutical agents.  However, the chemical synthesis approach is time 
consuming and very costly since the rate of new invented drugs, which are proven 
to be beneficial for clinical use, is very low.  It seems unlikely that efforts to modify 
the structures of existing agents will provide any new products that do not share 
similar toxicity.  Ethnopharmacology provide scientists with an alternative approach 
for the discovery of anti-inflammatory agents, namely the study of medicinal plants 
with a history of traditional use as a potential source of substances with significant 
pharmacological and biological activities.  This strategy may increase the likelihood 
of identifying new prototype drugs with quite different chemical structures and 
mechanisms of action and hence, lowers likelihood of similar toxicities.   
 In search for novel prototype anti-inflammatory agents, it seems reasonable 
to assume that new agents to be found have different structures with different or 
supplemental activities from the ones in current use or development.  In any event, 
the identification of a novel structure, with or without a novel mechanism of action, 
provides a prototype agent from which a new class of anti-inflammatory drugs may 
be derived.  By the same token, compounds which possess novel mechanism(s) of 
action, regardless of whether they become clinically useful, may serve as model 
compounds for synthetic or semisynthetic structure modifications and optimisation.  
In particular, the higher plants are a logical choice, chiefly because of their 
seemingly infinite variety of novel organic molecules.  Anti-inflammatory agents are 
widely distributed among the higher plants, but very few have been evaluated. 
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Salicin, methyl salicylate and wintergreen oil are the natural products from 
higher plants, which have reached clinical utility.  Moreover, salicin that is isolated 
from willow barks has served as a template for synthesis of aspirin (acetylsalicylic 
acid).  A diverse group of chemical structures including withanolides, coumarins, 
noelignans, peptides, steroids, triterpenoids, glycosides, alkaloids, phenolic 
compounds, tannins, flavonoids, cannabinoids and polysaccharides have been 
shown to possess anti-inflammatory activities (Sener & Bingöl, 1988; Duwiejua & 
Zeitlin, 1993; Bingöl & Sener, 1995).  Therefore, question arises as to whether anti-
inflammatory agent also can be isolated from Malaysian traditional plants. 
 In folk medicine, various indigenous herbal drugs are used, in single and or 
in combined forms, for treating different types of inflammatory and arthritic 
conditions, with considerable success.  The use of the plants to treat inflammation 
and many other diseases in Malaysia is similar to many other parts of the world.  For 
instance, rhizome Kaempferia galanga, rhizome Zingiber zerumbet and 
Elephantopus scaber (whole plant) are used in decocted form to treat pain and 
swelling (Asmawi et al., 1993).  Although the use of these herbal drugs has a sound 
tradition, and their medicinal uses and general safety are well known to native 
peoples, their place has yet to be rationalized in therapeutics, in the current setting. 
Scientific studies are therefore required to assess their efficacy and some of the 
medicinal properties as popularly claimed.   As part of study to seek new, more 
potent anti-inflammatory agent(s) with less side effects from plant origin, several 
Malaysian medicinal plants were screened for their ability to inhibit carrageenan 
induced hind paw oedema in rats.  The plants studied were traditionally used to treat 
swelling, fever, pain, and rheumatism, i.e. indications for the use of nonsteroidal 
anti-inflammatory drugs. 
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1.2 Aims of the study 
 The present study is part of a project undertaken to investigate the anti-
inflammatory activity of some traditional plants found in Malaysia.  Three medicinal 
plants, different plants parts and different extracts, were evaluated.  The plants and 
part studied were whole plant of Ageratum conyzoides Linn., leaves and the 
combination of other parts of the plant (flowers, stems, fruits) of Lantana camara 
Linn., and leaves of Psidium guajava Linn..  The specific objectives of this study are 
as follows: 
 
1. to optimise carrageenan-induced oedema, anti-inflammatory models so that 
it requires less extract sample for screening. 
2. to verify whether the traditional anti-inflammatory plants, Ageratum 
conyzoides Linn., Lantana camara Linn., Psidium guajava Linn. possess 
anti-inflammatory activity using carrageenan induced rats hind paws oedema 
as the anti-inflammatory screening model. 
3. to perform an anti-inflammatory activity guided fractionation on the Lantana 
camara Linn. leaves. 
4. to investigate the possible prostaglandin antagonist activity of active fractions  
of Lantana camara Linn., using oxytocin and acetylcholine induced 
contraction in isolated rat uterus preparation. 
5. to investigate the effect of active fraction of Lantana camara Linn. on the 
possible involvement of voltage-operated calcium channels (VOCCs) and 
intracellular channels in the isolated rat vas deferens preparations.  
6. to screen phytochemically the classes of compounds present in the active 
fractions of Lantana camara Linn. responsible for the anti-inflammatory 
activity. 
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Chapter 2  Literature Survey 
2.1 Inflammation 
 Inflammation may be considered a protective mechanism that on occasion 
becomes deregulated and leads to a chronic inflammation.  Inflammations are 
characterised into 5 cardinal symptoms i.e. heat, redness, pain, swelling and loss of 
function.  The systems of an inflammation are results of complex patho-physiological 
processes that include increased blood flow and vascular permeability, activation of 
humoral and cellular defence mechanisms, sensibilization and activation of 
nociceptors.  These processes are mediated by a variety of inflammatory mediators 
which are listed in Table 2.1.  The inflammatory process is triggered by several 
interrelated cascade systems in the body.  These are including the complement 
system, coagulation system, plasmakinin system and arachidonic acid cascade (Fig. 
2.1).   
INJURY
initiates activation of:
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MAST CELLS
PLATELET
AGGREG
COAGULATION
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HAGEMAN FACTOR
PREKALLIKREIN KALLIKREIN
KININS KININOGENSVASCULAR
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5-HTC3a,C5a
(cyclooxygenase) (lipoxygenase)
PGG2
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PGI 2
PGE 2
LTB 4
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arachidonic acid cascade
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Fig. 2.1 Schematic representation of the interactions between and subsequent 
effects of inflammatory substances on vasculature (Dawson & Willoughby, 
1985; Rang et al., 2007). 
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Table 2.1  Mediators of inflammation (Ammon et al., 1993; Dawson & Willoughby, 
1985; Rang et al., 2007). 
 
Mediator  Origin Inflammation systems 
Serotonin (5-
hydroxytryptamine) 
Mast cell Increased vascular permeability 
Histamine Mast cell, Basophilic 
granulocytes. 
Vasodilatations, increased vascular 
permeability, pain 
Bradykinin Plasma Vasodilatations, increased vascular 
permeability, pain 
Prostagladins Ubiquitous Vasodilatations, pain sensitization 
against bradykinin and histamine  
Thromboxane Thrombocytes, other 
cells 
Platelet activation 
Leucotrienes Leucocytes Chemotactic for leucocytes, 
increased vascular permeability 
Lysosomal enymes Leucocytes, synovial 
cells 
Necrotic, Chemotactic for leucocytes, 
Platelet-activating 
factor 
Polymorphonuclear 
leukocytes, 
Macrophages, 
Eosinophils, Mast 
cells 
Vasodilatations, increased vascular 
permeability, Aggregation of platelets, 
Chemotactic for leucocytes, 
increased enzyme secretion, initiation 
of free radical release. 
Complement 
components 
Blood Increased vascular permeability, 
chemoattration, immune adherence, 
leukocytosis 
Cytokines 
(lymphokines, 
chemokines, 
interferon, 
interleukins, tumour 
necrosis factor) 
Leukocytes, 
Macrophages 
Adhesion molecule expression, 
cell growth, division, differentiation, or 
programmed cell  death, 
immunoglobulin production, 
chemotaxis.  
 
2.2 Cycloxygenase pathway and prostaglandin 
Cycloxygenase (COX) pathways have long been targeted for the treatment 
of inflammatory, initially through the use of NSAIDs.  Cyclooxygenase activity is 
known to be the consequence of the activition of different isoenzymes, including 
COX 1, COX 2, and a COX 1 variant, COX 3 (Gale et al, 2007).  These enzymes 
use arachidonic acid as a substrate to form prostaglandins.  COX isozymes are 
membrane-associated and internalize adjacent arachidonic acid, which is released 
when membrane damage occurs. COX 1 is expressed constitutively in most tissues, 
and is responsible for the production of PGs that control normal physiologic 
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functions including of PGs that control normal physiologic functions including flow, 
and platelet aggregation. COX 2 is not constitutively expressed, but is rapidly 
induced by both inflammatory and mitogenic stimuli resulting in increased PG 
synthesis in neoplastic and inflamed tissues (Wu, 2005). 
Prostaglandins are synthesized by most cells in the human body. The 
biosynthesis of prostaglandin via the cyclooxygenase  (COX) pathway is initiated by 
the release of arachidonic acid (AA) from membrane phospholipids by 
phospholipases, followed by the conversion of AA to prostaglandin G2 (PGG2) by the 
COX activity of the COX enzymes,  PGG2 is then immediately converted into PGH2 
by the hydroperoxidase activity of COX.  The synthesis of PGH2 by COX is coupled 
with modification by downstream cellspecific isomerase enzymes, resulting in the 
production of prostaglandin products in a tissue-specific manner.  Prostaglandins act 
at or near the sites of synthesis by binding to specific receptors on the cell surface 
which results in a wide range of biological effects, including the relaxation or 
contraction of blood vessels, platelet aggregation as well as pain and fever 
generation (Gale et al, 2007).   
 
2.3 Principles of anti-inflammatory drug action 
 
 Pharmacological control of inflammation can be achieved by two separate 
mechanisms: (i) by antagonizing or preventing the release of mediators involved in 
initiating or amplifying inflammation, (ii) by direct action on inflammatory cells 
affecting their response of function (Sedgwick & Willoughby, 1985).  Anti-
inflammatory compounds can act on many steps of the pathophysiological 
processes.  It might block the biosynthesis of proinflammtory mediators by direct 
interaction with a key enzyme (e.g., inhibition of cyclooxgenase-II or 
lipooxygenases) or by decreasing enzyme expression (e.g., steroidal anti-
inflammatory compounds) or by reducing substrate levels (e.g., decreased of 
arachidonic acid).  Alternatively or in addition, it can act by inhibiting the release of 
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preformed, stored mediators (e.g., histamine release) or block mediator receptors 
interaction on target cells (e.g., leukotrience receptor antagonists).  An anti-
inflammatory compound may also act by immunostimulation (e.g., maturation of 
myeloid cells, stimulated phagocytosis) that in turn promotes an increased removal 
of the insulting signal molecules (organisms or alternatively, by immunosupression) 
that results in less aggressive inflammatory response to allergen challenge (Safayhi 
& Sailer, 1997).  The prevention of inflammation is simplified in Fig. 2.2. 
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Fig. 2.2 Simplified diagram of the inflammatory response and its prevention 
(Rang et al., 2007; Sedgwick & Willoughby, 1985). 
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2.4 Plant-derived medicinals 
 The importance of plant-derived medicinals in modern medicine is often 
underestimated. Such useful compounds as digitoxin, rutin, papain, morphine, 
codeine, papaverine, atropine, scopolamine, quinine, quinidine, reserpine, 
ergotamine, ergonovine, cocaine, vincaleukoblastine, leurocristine, d-tubocurarine, 
protoveratrines A and B, ephedrine, sparteine, physostigmine, pilocarpine, 
colchicines, and caffeine present a broad and representative range of 
pharmacologic activities.  Amongst our most invaluable orthodox medicines derived 
from compounds in higher plants are analgesic agents (e.g. morphine and codeine), 
antimalarial treatments (e.g. quinine), antitumour drugs (e.g. vincristine and taxol) 
and asthma therapies (e.g. cromoglycate).  An analysis of the top-selling 
pharmaceuticals for 1999 shows that 13 of the top-selling 30 medicines, with 
combined sales of over $26 billion, have active ingredients whose chemical 
structure is based on a compound found originally in nature (Table 2.2)  
(O’ Neill & Lewis, 2002). 
 
Table 2.2 Top-selling medicines for 1999 in $billion.  Those in italics have a 
structure based on a compound discovered in nature (O’ Neill & Lewis, 
2002). 
Medicines $billion Medicines $billion 
Omeprazole 5.85 Ciprofloxacin 1.64 
Simvastatin 4.37 Risperidone 1.47 
Atorvastatin 3.68 Taxol 1.44 
Erythropoetin 3.68 Celecoxib 1.43 
Pravastatin 3.26 Cyclosporin 1.42 
Amlodipine 2.98 Losartan 1.36 
Fluoxetine 2.93 Clarithromycin 1.32 
Loratidine 2.82 Human Insulin 1.30 
Enalapril 2.24 CSF 1.21 
Sertraline 2.09 Azithromycin 1.21 
Paroxetine 2.01 Ceftriaxone 1.21 
Olanzapine 1.83 Lisinoprol 1.20 
Conjugated oestrogens 1.83 Sumatriptan 1.09 
Lansoprazole 1.80 Interferon 1.09 
Amox-Clav 1.69 Nifedipine 1.09 
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2.5 Ageratum conyzoides Linn. (Asteraceae) 
Species : Ageratum conyzoides Linn. 
Family  : Asteraceae or Compositae 
Local Name : Rumput tahi ayam (Mustafa & Muhamad, 1994) 
 
 
 
Plate 1.1 Ageratum conyzoides Linn. 
 
 
Ageratum conyzoides Linn., is an annual herb with a long history of 
traditional medicinal uses in many countries in the world (Table 2.3), especially in 
the tropical and subtropical regions. A wide range of chemical compounds including 
alkaloids, flavonoids, chromenes, benzofurans and terpenoids have been isolated 
from this species (Table 2.4). Extracts and metabolites from this plant have been 
found to possess pharmacological activities (Table 2.5). (Okunade, 2002) 
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Table 2.3 Traditional medicinal uses of Ageratum conyzoides Linn. (Okunade, 
2002). 
 
Region / Country Uses 
Githen use as purgative, febrifuge, opthalmia, colic; treatment of ulcers 
and wound dressing 
Senegal antienteralgic and antipyretic 
some African 
countries 
treatment of mental and infectious diseases as well as 
headaches and dyspnoea 
Cameroon remedy for craw-craw 
Nigeria skin diseases and wound healing, treat diarrhoea and to relieve 
pain associated with navel in children 
Central Africa used to treat wounds caused by burns 
Kenya  
(East Africa) 
antiasthmatic, antispasmodic and haemostatic 
India treatment of leprosy and as an oil lotion for purulent opthalmia 
Brazil anti-inflammatory, analgesic and anti-diarrhoeic 
Vietnam treatment of gynaecological diseases 
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Table 2.4 The classes of chemical constituents isolated from Ageratum 
conyzoides Linn. (Okunade, 2002). 
 
Class Compound 
essential oil • (+)-sesamin  
• aurantiamide acetate 
• fumaric acid 
• caffeic acid 
• phytol 
• (Z)12-6-methyl-heptadecenoic acid 
 
essential oil –
monoterpenes 
• sabinene 
• β-pinene 
• β -phellandrene 
• 1,8-cineole 
• limonene 
• terpinen-4-ol 
• α-terpineol 
• Ocimene 
• α-Pinene 
• eugenol 
• methyleugenol 
 
essential oil –
sesquiterpenes 
• β-caryophyllene 
• δ-Cadinene 
• sesquiphellandrene 
• caryophyllene epoxide 
 
essential oil – 
chromene 
• 7-methoxy-2,2-dimethylchromene (precocene I) 
• 6,7-dimethoxy derivative, ageratochromene (precocene II) 
• ageratochromene dimer 
• encecalin 
• 6-vinyl-7-methoxy-2,2-dimethylchromene 
• dihydroencecalin 
• dihydrodemethoxyencecalin 
• demethoxyencecalin 
• demethylencecalin 
• 2-(1'-oxo-2'-methylpropyl)-2-methyl-6,7-dimethoxychromene 
 
Chromene • 2,2-dimethylchromene-7-O- β-glucopyranoside 
• 6-(1-methoxyethyl)-7-methoxy-2,2-dimethylchromene 
• 6-(1-hydroxyethyl)-7-methoxy-2,2-dimethylchromene 
• 6-(1-ethoxyethyl)-7-methoxy-2,2-dimethylchromene 
• 6-angeloyloxy-7-methoxy-2,2-dimethylchromene 
• Encecanescins 
 
Benzofuran • 2-(2'-methylethyl)-5,6-dimethoxybenzofuran 
• 14-hydroxy-2H β,3-dihydroeuparine 
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Table 2.4 The classes of chemical constituents isolated from Ageratum 
conyzoides Linn. (Okunade, 2002). (Continued) 
 
Class Compound 
Chromone • 3-(2'-methylpropyl)-2-methyl-6,8-dimethoxychrom-4-one 
• 2-(2'-methylprop-2'-enyl)-2-methyl-6,7-dimethoxychroman-4-
one 
 
Flavonoids • 5'-methoxynobiletin 
• linderoflavone B 
• 5,6,7,3',4',5'-hexamethoxyflavone 
• eupalestin 
• scutellarein-5,6,7,4'-tetrahydroxyflavone 
• quercetin 
• quercetin-3-rhamnopiranoside 
• kaempferol 
• kaempferol -3- rhamnopiranoside 
• kaempferol 3,7-diglucoyside 
• isoflavone 
 
Triterpene • friedelin 
 
Sterol • β-sitosterol 
• stigmasterol 
• brassicasterol 
• dihydrobrassicasterol 
• spinasterol 
• dihydrospinasterol 
 
pyrrolizidine 
alkaloids 
• lycopsamine 
• echinatine 
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Table 2.5 Biological activity of Ageratum conyzoides Linn. (Okunade, 2002). 
 
Extracts  / Metabolites Activity 
crude extract of the whole 
plant 
• as a wound dressing 
• possess neuromuscular blocking activity in 
isolated rats phrenic nerve-diaphragm 
• caused greater fall in diastolic pressure 
compared to systolic pressure in 
anaesthetized rats 
• possess calcium channels blocking activity 
leaves extract • treatment of chronic pain in osteoarthritic 
patients 
• analgesic activity 
methanolic extract of the 
whole plant 
• antimicrobial activity 
aqueous extract of the 
leaves 
• prevent coagulation of the whole blood while 
causing precipitation of some blood materials 
water soluble fraction (WSF) 
of the plant extract 
• possess a peripheral analgesic activity and 
an anti-inflammatory action 
• possess direct relaxing effect on smooth 
muscles and inhibit contraction induced by 
several agonists 
essential oil • anti-inflammatory - cotton pellet granuloma 
• analgesic - tail-flick and writhing test activity 
• antipyretic  activity -brewer's yeast injection 
• antibacterial - 20 bacteria  
• antifungal activities - 4 fungi  (Candida 
albicans SP-14, Cryptococcus neoformas SP-
16, Sclerotium rolfsii SP-5 and  Trichophyton 
mentagrophytes SP-12.) 
demethoxyageratochromene • against two of the fungi, Penicillium 
chrysogenum and P. javanicum 
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2.6 Lantana camara Linn. (Verbenaceae) 
Species : Lantana camara Linn. 
Family  : Verbenaceae 
Local Name : Bunga tahi ayam busuk, tahi ayam munai, bunga tahi anjing, bunga 
tahi asu, bunga tahi ayam, bunga pagar, bunga asam senyur 
(Mustafa & Muhamad, 1994) 
 
 
 
Plate 1.2 Lantana camara Linn. 
 
 
 Lantana camara Linn. is regarded both as a notorious weed and a popular 
ornamental garden plant and has found various uses in folk medicine in many parts 
of the world (Table 2.6) (Ross, 1999).  The L. camara Linn. plant contains different 
classes of constituents listed in Table 2.7.  Some taxa of the widely variable L. 
camara Linn. complex are toxic to small ruminants and this effect has been 
associated with the types and relative amounts of some triterpene ester metabolites. 
However, L. camara linn. also produces a number of metabolites in good yields and 
some have been shown to possess useful biological activities (Table 2.8). 
(Ghisalberti, 2000) 
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Table 2.6 Traditional medicinal uses of Lantana camara Linn. (Ross, 1999).   
 
Region / Country Uses 
Australia • To treat neurodermatitis, eczema, rashes, psoriasis, tinea, 
chicken pox, boils, bites, whooping cough, catarrh, pulmonary 
problems, epidermic parotiditis, and fever 
• To stop bleeding in traumatic injuries. 
Brazil • To treat mange, malaria, fevers, colds, headache. 
Canary Islands • Taken by pregnant women as an abortifacient. 
Colombia • To facilitate childbirth and as an emmenagogue. 
East Africa • To treat sore throat, cough, toothache, headache, and colds.  
• As a diaphoretic, stimulant, for jaundice, chest diseases, and for 
rheumatism. 
Guatemala • Taken orally to treat rheumatism, constipation and eczema 
• Taken orally as a tonic and stimulant 
• Used externally for wounds, ulcers, bruises, and sores 
India • Used externally for chronic ulcers. 
• Applied to the eye for eye injuries. 
Indonesia • Taken orally to treat gonorrhoea, leucorrhoea, intestinal spasm, 
rheumatism, and cough. 
• Used as emetic, diaphoretic, tonic, diaphoretic, carminative, and 
antiseptic. 
• Applied to skin to treat boils and wounds. 
Kenya • Dried stem is used as toothbrush 
Mexico • Given orally to treat rheumatism, snakebite, vomit, dysentery, 
gastrointestinal pain, toothache, uterine haemorrhage, excess 
menstrual discharge, rashes, and coughs. 
• The whole plant is rubbed with cold water to treat chills. 
• Taken orally as a stomach tonic and as an appetizer. 
Nigeria • Taken orally as an antiasthmatic, tonic, and anticonvulsant. 
Panama • To treat colds, stomach afflictions, digestive disorders, and skin 
diseases. 
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Table 2.6 Traditional medicinal uses of  Lantana camara Linn. (Ross, 1999).  
(Continued) 
 
Region / Country Uses 
Rwanda • Taken orally for malaria. 
Southeast Asia • To treat swelling on skin cuts, rheumatism, bilious fever. 
Surinam • Used as an herbal bath. 
Tanzania • Taken orally for stomachache and against vomiting. 
• Used externally for itching and rashes. 
Thailand • Taken orally for asthma. 
• Used as a poultice for anti-inflammatory infections. 
Tonga • Applied to cuts to prevent infection. 
USA • Taken orally as a carminative. 
Venda • Used as a eye drop for eye injury. 
Venezuela • Taken orally as an emmenagogue. 
Vietnam • Taken orally as an emmenagogue. 
West Africa • Taken orally to treat coughs, colds, jaundice, and chest pain. 
• Used as a diaphoretic, and also stimulant. 
• Used in bath for rheumatism 
West Indies • Taken orally for dysmenorrhoea, fever, cough, flu, and indigestion. 
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Table 2.7 The classes of chemical constituents isolated from Lantana camara 
Linn. (Ghisalberti, 2000).   
 
Class Compound Class Compound 
essential oils • safrole 
• humulene 
• davanone 
 
sterol • β–sitosterol 
• campesterol 
• stigmasterol 
• β-sitosterol glucoside 
 
essential oils – 
sesquiterpenes 
• β-curcumene  
• (E)-nuciferal 
• (Z)-nuciferol 
• (-)-ar-curcumen-15-al 
• γ-curcumene 
• ar-curcumene 
• (-)-epi-β-bisabolol 
• (-)-γ-curcumen-15-al 
• caryophyllene 
 
phenyl 
ethanoid 
glycosides 
• verbascoside 
• (Z)- verbascoside 
• isoverbascoside 
• martynoside 
• derhamnosyl-
verbascoside 
• isonuomioside A 
• calceolarioside E 
 
Triterpenes • lantadene A 
• lantadene B 
• lantadene C 
• lantadene D 
• reduced lantadene A 
• lantanolic 
• lantic acid 
• icterogenin 
• oleanolic acid 
• Ursolic acid 
 
flavonoids • 3-methoxyquercetin 
• 3,7-dimethoxyquercetin 
• 3,7,4'-
trimethoxyquercetin 
• hispidulin 
• pectolinarigenin 7-O- β-
D-glucoside 
• flavone glycoside 
camaraside 
 
iridoid glycosides • theveside 
• theviridoside 
• geniposide 
• 8-epiloganin 
• shanzhside methyl 
ester 
• lamiridoside 
 
oligo-
saccharides 
• ajugose  
• stachyose 
• verbascotetraose 
• verbascose 
• lantanose A 
• lantanose B 
 
furanonaphtho-
quinones 
• quinone 
diodantunezone 
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Table 2.8 Biological activity of metabolites isolated from Lantana camara Linn.  
(Ghisalberti, 2000). 
 
Class Compound Biological activity 
pentacyclic 
triterpenes 
ursolate acetate • antimicrobial - active (30 µg/disk) against 
Staphylococcus aureus and S. typhi 
• antimutagenic activity - reduced the number 
of micronucleated polychromatic erythrocytes 
induced by mitomycin C 
lantadene A • inhibited Epstein–Barr virus activation in Raja 
cells induced by 12-O-tetradecanoylphorbol-
13-acetate (TPA) 
• possess inhibitory effects on the two-stage 
carcinogenesis of mouse skin papillomas 
lantadene B • inhibited Epstein–Barr virus activation in Raja 
cells induced by 12-O-tetradecanoylphorbol-
13-acetate (TPA) 
• as an inhibitors of tumour promoters in vivo 
• possess inhibitory effects on the two-stage 
carcinogenesis of mouse skin papillomas 
• delayed the formation of papillomas on 
mouse skin, reduced the rate of papilloma-
bearing mice (by 15% at 20 weeks) and 
reduced the average number of 
papillomas/mouse (50% at 20 weeks) 
lantadene C • inhibited Epstein–Barr virus activation in Raja 
cells induced by 12-O-tetradecanoylphorbol-
13-acetate (TPA) 
• as an inhibitors of tumour promoters in vivo 
reduced 
lantadene A 
• inhibited Epstein–Barr virus activation in Raja 
cells induced by 12-O-tetradecanoylphorbol-
13-acetate (TPA) 
oleanolic acid • as an inhibitors of human leucocyte elastase 
• possess inhibitory effects on inflammation 
and on various stages of tumour development 
• possess COX-2 inhibitory effect with an IC50 
295 µM and a COX-2/COX-1 selectivity ratio 
of 0.8 
ursolic acid  as an inhibitors of human leucocyte elastase  
• possess inhibitory effects on inflammation 
and on various stages of tumour development 
• possess COX-2 inhibitory effect with an IC50 
value of 130 µM and a COX-2/COX-1 
selectivity ratio of 0.6 
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Table 2.8 Biological activity of metabolites isolated from Lantana camara Linn. 
(Ghisalberti, 2000).  (Continued) 
 
Class Compound Biological activity 
iridoid 
glycosides 
geniposide • inhibited hepatoxicity and the DNA repair 
synthesis induced by aflatoxin B1 in rat 
primary hepatocytes 
• showed hypolipidemic activity in 
hyperlipidemic rats 
• showed cAMP phosphodiesterase inhibitory 
activity 
Furanonaphtho
quinones 
diodantunezone • possess cytotoxicity against KB epidermoid 
nasopharynx, K562 human leukaemia and 
P388 lymphocytic leukaemia cell lines and 
found to be active (IC50 6.76, 9.2 and 7.94 
µmol/l, respectively) 
phenylethanoid 
glycosides 
verbascoside 
(syn: acteoside, 
kusaginin) 
• inhibited PKC in a concentration-dependent 
manner and showed an IC50 of 25 µM 
• inhibited rabbit lens aldolase reductase and 
lipid peroxidation 
• exhibited immunomodulating activity and 
immunosuppressive properties 
• potentiated the anti-tremor effect of DOPA 
• against murine P-388 lymphocytic leukaemia 
in vivo (ED50 2.6 µg/ml compared to 
isoverbascoside ED50 10 µg/ml) 
• antiproliferative effect in vitro against L-1210 
cells (IC50 13 µM) 
• analgesic activity 
• protection against oxidative haemolysis  
• antibacterial activity (E. coli) and was active 
against the Aujeszky virus 
• as a cardiotonic and vasodilatory agent 
increased levels of cAMP and of prostacyclin 
• exhibited activity against respiratory syncytial 
virus (EC50 0.80 µg/ml; cytotoxicity, IC50 
76.9 µg/ml; selective index, SI 85.4) 
martynoside • increased (16%) chronotropism and coronary 
perfusion rate (44%) in the Langendorff 
isolated rat heart1 
isoverbascoside • exhibited activity against respiratory syncytial 
virus (EC50 0.0.62 µg/ml; IC50 51.4 µg/ml; SI 
84) 
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2.7 Psidium guajava Linn. (Myrtaceae) 
Species : Psidium guajava Linn. 
Family  : Myrtaceae 
Local Name : Jambu burung, jambu padang, jambu berasu, jambu bereksa, 
jambu buyawas, jambu melukut, jambu Portugal, jambu batu, jambu 
pelawas, jambu biji, jambu biyawas (Mustafa & Muhamad, 1994). 
 
 
 
Plate 1.3 Psidium guajava Linn. 
 
 
 Psidium guajava Linn. also known as the guava plant, is used in 
ethnomedicine for the treatment of various human ailments (Table 2.9) (Ross, 
1999).  Phytochemical studies undertaken by different groups of workers on different 
parts of the plant have resulted in the isolation and identification of various 
terpenoids, flavonoids and tannins (Table 2.10) (Begum et al., 2002; Ross, 1999).  
Extracts of P. guajava Linn. have been shown to possess several pharmacological 
actions (Table 2.11) (Begum et al., 2002; Olajide et al., 1999; Ross, 1999). 
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Table 2.9 Traditional medicinal uses of Psidium guajava Linn. (Ross, 1999). 
 
Region / 
Country 
Parts of 
the plant 
Uses 
Brazil Fruit • Taken orally to treat diarrhoea, stomachache, 
and diabetes. 
Canary Islands Fruit • Used as an antihemorrhoidal. 
China Roots • Taken orally to suppress libido. 
Cook Islands Leaves • Relieve postpartum pain and rid the body of 
residual stale blood. 
Fiji Fruit • Taken orally for constipation. 
Leaves • Taken orally for diarrhoea, indigestion, 
dysentery, and upset stomach. 
Guam Leaves • To treat vaginitis and to promote conception. 
Guatemala Bark and 
leaves 
• Taken orally to treat fevers, respiratory ailments, 
and skin infections. 
Fruit • Powdered and eaten for stomach cramps. 
Haiti Leaves 
and fruit 
• Taken orally for diarrhoea. 
India Flowers 
and buds 
• Taken orally as an anthelmintic. 
• Used for diarrhoea, high fever, headache, and 
jaundice. 
• Used as antiemetic, remedy for stomachache. 
Leaves • Taken orally for diarrhoea and as an antiemetic. 
Fruits • Used for jaundice. 
Bark • Taken orally as a remedy for stomachache. 
Indonesia Leaves • Taken orally as an emmenagogue. 
Japan Root • Taken orally as a suppressant of libido. 
Madagascar Leaves • Taken orally for diarrhoea. 
Malaysia Bark and 
leaves 
• Taken orally to expel the placenta, as an 
emmernagogue, and for after-birth disorders. 
Mexico Bark • Taken orally for dysentery. 
Fruits • Taken orally as a digestive. 
Leaves • Used externally as a treatment for mange. 
• Taken orally for diarrhoea. 
Nigeria Root • Taken orally for diarrhoea. 
Panama Bark and 
Fruits 
• Taken orally for diarrhoea. 
Flowers 
and fruits 
• Taken orally as an emmenagogue. 
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Table 2.9 Traditional medicinal uses of Psidium guajava Linn. (Ross, 1999). 
(Continued) 
 
Region / 
Country 
Parts of 
the Plant 
Uses 
Papua-New 
Guinea 
Leaves • Taken orally for diarrhoea. 
Peru Bark, 
leaves and 
root 
• Taken orally as an astringent, antihemorrhagic, 
antidiarrheal, and for stomach pain. 
Philippines Bark • Used in steam baths postpartum. 
Rarotonga Leaves • Taken orally for dysentery. 
Rwanda Leaves • Taken orally for dysentery. 
Senegal Leaves 
and fruits 
• Taken orally for diarrhoea, and dysentery. 
Sierra Leone Leaves • Taken orally for diarrhoea during pregnancy. 
Taiwan Fruits • Taken orally to treat diabetes mellitus. 
Branches • Taken orally for liver diseases. 
Tanzania Leaves • Taken orally for malaria, and skin diseases. 
Thailand Leaves • Taken orally for diabetes. 
Venda Roots • Taken orally for venereal diseases. 
 
 
